# FOXA2

## Overview
FOXA2 is a gene that encodes the forkhead box A2 protein, a transcription factor belonging to the Forkhead box (FOX) family. This protein is characterized by its winged-helix DNA-binding domain, which allows it to interact with chromatin and regulate gene expression. FOXA2 plays a pivotal role in the development and function of several organs, including the liver and pancreas, where it influences metabolic processes and cellular differentiation. It is involved in the regulation of glucose and lipid metabolism, as well as the differentiation of pancreatic β and α cells. The protein's activity is modulated by various post-translational modifications and interactions with other proteins, which affect its stability and transcriptional activity. Mutations in the FOXA2 gene have been linked to congenital disorders and certain cancers, highlighting its significance in both developmental biology and disease pathology (Choi2020Inactivation; Giri2017Novel; Yu2023The).

## Structure
FOXA2, a member of the Forkhead box (FOX) family, is characterized by a conserved winged-helix DNA-binding domain known as the forkhead box. This domain is structurally similar to linker histones, enabling FOXA2 to unwind chromatin and recruit transcriptional cofactors to gene promoters (Choi2020Inactivation; Belaguli2012Forkhead). The protein's C-terminus interacts with histones H3 and H4 within nucleosomes, facilitating chromatin opening (Choi2020Inactivation).

FOXA2 undergoes several post-translational modifications that influence its activity and stability. Phosphorylation by AKT/PKB at threonine 156 promotes nuclear export, while phosphorylation at serine 107/111 affects subcellular localization (Choi2020Inactivation). Acetylation at lysine 259 by P300 acetyltransferase leads to nuclear accumulation and increased gene expression, whereas deacetylation by SIRT1 reduces expression and promotes nuclear export (Choi2020Inactivation). Sumoylation at lysine 6 is crucial for FOXA2's stability and enhances its transcriptional activity (Belaguli2012Forkhead).

The protein's structure and function are further modulated by its interaction with other proteins and its role in transcriptional regulatory networks, particularly in liver development and metabolism (Bochkis2012GenomeWide).

## Function
FOXA2 is a transcription factor that plays a critical role in the development and function of the liver and pancreas. In the liver, FOXA2 is involved in early liver specification and differentiation by inducing the expression of albumin and other hepatic markers. It helps maintain liver function in adults by promoting the binding of HNF4a to enhancers, stabilizing the expression of developmentally induced genes, and supporting the adult liver regulatory network (Yu2023The). FOXA2 also regulates glucose and lipid metabolism, influencing processes such as gluconeogenesis, glycolysis, and fatty acid oxidation. It is involved in mitochondrial beta-oxidation and ketogenesis, and its activity is modulated by insulin signaling (Yu2023The).

In the pancreas, FOXA2 is essential for the initiation of pancreatic development and the differentiation of pancreatic β cells. It regulates insulin secretion and glucose homeostasis by influencing the expression of genes related to the K-ATP channel, which is crucial for insulin release (Lantz2004Foxa2; Yu2023The). FOXA2 also plays a role in the differentiation of pancreatic α cells and the regulation of glucagon gene expression (Yu2023The). Its activity in the nucleus involves binding to DNA and facilitating chromatin remodeling, which is necessary for the transcription of target genes (Yu2023The).

## Clinical Significance
Mutations in the FOXA2 gene are associated with a range of congenital and acquired conditions. A novel mutation, c.505T>C, p.S169P, in FOXA2 has been linked to a complex congenital syndrome characterized by congenital hypopituitarism (CH), congenital hyperinsulinism (CHI), craniofacial dysmorphic features, and abnormalities in endoderm-derived organs such as the liver, lung, and gastrointestinal tract. This mutation impairs transcriptional activity and reduces FOXA2 protein expression, contributing to the clinical phenotype (Giri2017Novel).

FOXA2 mutations have also been implicated in endometrioid endometrial cancer (EEC), where they predominantly result in frameshifts or stop mutations, leading to truncated protein products. These mutations suggest a tumor suppressor role for FOXA2 in the endometrium, although they do not follow the typical two-hit model of tumor suppressor genes (Sahoo2022FOXA2; Smith2016The).

In pancreatic development, FOXA2 haploinsufficiency can lead to aberrant development of pancreatic beta cells, potentially resulting in diabetes. FOXA2 mutations have been associated with both hypoglycemic and hyperglycemic conditions, similar to some MODY gene mutations (Elsayed2021Aberrant). These findings underscore the critical role of FOXA2 in various developmental and disease processes.

## Interactions
FOXA2, a transcription factor, engages in various interactions with proteins and nucleic acids, influencing gene expression and chromatin structure. In non-small cell lung cancer, FOXA2 interacts with proteins such as myosin 9, HSP90A, GRP78 precursor, and HSPA1A. These interactions were identified using MALDI-TOF/MS analysis and confirmed through co-immunoprecipitation and immunoblot analysis. Notably, FOXA2 interacts with HDAC family proteins, specifically HDAC1 and HDAC3, which repress its transcriptional activity on target promoters (Jang2015Transcription).

In prostate and epididymal tissues, FOXA2 interacts with the androgen receptor (AR) through its DNA binding domain, as demonstrated by GST-pull down experiments. This interaction allows FOXA2 to regulate gene expression in these tissues, including the activation of the prostate-specific PSA promoter and suppression of androgen induction on the mE-RABP promoter (YU2005Foxa1).

In breast cancer cells, FOXA2 interacts with FOXP2, a transcription factor that prevents epithelial-mesenchymal transition (EMT) by stimulating E-cadherin transcription. This interaction involves specific regions of both proteins and is crucial for the transcriptional activation of E-cadherin, impacting the EMT process (Liu2021FOXA2Interacting).

FOXA2 also interacts with HNF6, forming a regulatory loop where HNF6 acts as a coactivator to enhance FOXA2's transcriptional activity. This interaction involves the recruitment of p300/CBP histone acetyltransferase proteins, which are essential for the transcriptional regulation of HNF6 target genes (Lehner2010Inhibition).


## References


[1. (YU2005Foxa1) XIUPING YU, APARNA GUPTA, YONGQING WANG, KICHIYA SUZUKI, JANNI MIROSEVICH, MARIE‐CLAIRE ORGEBIN‐CRIST, and ROBERT J. MATUSIK. Foxa1 and foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Annals of the New York Academy of Sciences, 1061(1):77–93, December 2005. URL: http://dx.doi.org/10.1196/annals.1336.009, doi:10.1196/annals.1336.009. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1196/annals.1336.009)

[2. (Lehner2010Inhibition) Frank Lehner, Ulf Kulik, Juergen Klempnauer, and Juergen Borlak. Inhibition of the liver enriched protein foxa2 recovers hnf6 activity in human colon carcinoma and liver hepatoma cells. PLoS ONE, 5(10):e13344, October 2010. URL: http://dx.doi.org/10.1371/journal.pone.0013344, doi:10.1371/journal.pone.0013344. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0013344)

[3. (Yu2023The) Chuchu Yu, Xiaojing Li, Yu Zhao, and Yiyang Hu. The role of foxa family transcription factors in glucolipid metabolism and nafld. Frontiers in Endocrinology, January 2023. URL: http://dx.doi.org/10.3389/fendo.2023.1081500, doi:10.3389/fendo.2023.1081500. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2023.1081500)

[4. (Sahoo2022FOXA2) Subhransu S. Sahoo, Susmita G. Ramanand, Yunpeng Gao, Ahmed Abbas, Ashwani Kumar, Ileana C. Cuevas, Hao-Dong Li, Mitzi Aguilar, Chao Xing, Ram S. Mani, and Diego H. Castrillon. Foxa2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity. Journal of Clinical Investigation, June 2022. URL: http://dx.doi.org/10.1172/jci157574, doi:10.1172/jci157574. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci157574)

[5. (Liu2021FOXA2Interacting) Yuxiang Liu, Taolin Chen, Mingyue Guo, Yu Li, Qian Zhang, Guixiang Tan, Li Yu, and Yongjun Tan. Foxa2-interacting foxp2 prevents epithelial-mesenchymal transition of breast cancer cells by stimulating e-cadherin and phf2 transcription. Frontiers in Oncology, February 2021. URL: http://dx.doi.org/10.3389/fonc.2021.605025, doi:10.3389/fonc.2021.605025. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.605025)

[6. (Smith2016The) B. Smith, R. Neff, D.E. Cohn, F.J. Backes, A.A. Suarez, D.G. Mutch, C.M. Rush, C.J. Walker, and P.J. Goodfellow. The mutational spectrum of foxa2 in endometrioid endometrial cancer points to a tumor suppressor role. Gynecologic Oncology, 143(2):398–405, November 2016. URL: http://dx.doi.org/10.1016/j.ygyno.2016.08.237, doi:10.1016/j.ygyno.2016.08.237. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.ygyno.2016.08.237)

[7. (Jang2015Transcription) Sang-Min Jang, Joo-Hee An, Chul-Hong Kim, Jung-Woong Kim, and Kyung-Hee Choi. Transcription factor foxa2-centered transcriptional regulation network in non-small cell lung cancer. Biochemical and Biophysical Research Communications, 463(4):961–967, August 2015. URL: http://dx.doi.org/10.1016/j.bbrc.2015.06.042, doi:10.1016/j.bbrc.2015.06.042. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2015.06.042)

[8. (Choi2020Inactivation) Woosuk Choi, Shawn Choe, and Gee W. Lau. Inactivation of foxa2 by respiratory bacterial pathogens and dysregulation of pulmonary mucus homeostasis. Frontiers in Immunology, March 2020. URL: http://dx.doi.org/10.3389/fimmu.2020.00515, doi:10.3389/fimmu.2020.00515. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2020.00515)

[9. (Giri2017Novel) Dinesh Giri, Maria Lillina Vignola, Angelica Gualtieri, Valeria Scagliotti, Paul McNamara, Matthew Peak, Mohammed Didi, Carles Gaston-Massuet, and Senthil Senniappan. Novel foxa2 mutation causes hyperinsulinism, hypopituitarism with craniofacial and endoderm-derived organ abnormalities. Human Molecular Genetics, 26(22):4315–4326, August 2017. URL: http://dx.doi.org/10.1093/hmg/ddx318, doi:10.1093/hmg/ddx318. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddx318)

[10. (Belaguli2012Forkhead) Narasimhaswamy S. Belaguli, Mao Zhang, F. Charles Brunicardi, and David H. Berger. Forkhead box protein a2 (foxa2) protein stability and activity are regulated by sumoylation. PLoS ONE, 7(10):e48019, October 2012. URL: http://dx.doi.org/10.1371/journal.pone.0048019, doi:10.1371/journal.pone.0048019. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0048019)

[11. (Elsayed2021Aberrant) Ahmed K. Elsayed, Ihab Younis, Gowher Ali, Khalid Hussain, and Essam M. Abdelalim. Aberrant development of pancreatic beta cells derived from human ipscs with foxa2 deficiency. Cell Death &amp; Disease, January 2021. URL: http://dx.doi.org/10.1038/s41419-021-03390-8, doi:10.1038/s41419-021-03390-8. This article has 22 citations.](https://doi.org/10.1038/s41419-021-03390-8)

[12. (Lantz2004Foxa2) Kristen A. Lantz, Marko Z. Vatamaniuk, John E. Brestelli, Joshua R. Friedman, Franz M. Matschinsky, and Klaus H. Kaestner. Foxa2 regulates multiple pathways of insulin secretion. Journal of Clinical Investigation, 114(4):512–520, August 2004. URL: http://dx.doi.org/10.1172/jci200421149, doi:10.1172/jci200421149. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci200421149)

[13. (Bochkis2012GenomeWide) Irina M. Bochkis, Jonathan Schug, Diana Z. Ye, Svitlana Kurinna, Sabrina A. Stratton, Michelle C. Barton, and Klaus H. Kaestner. Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators foxa1 and foxa2. PLoS Genetics, 8(6):e1002770, June 2012. URL: http://dx.doi.org/10.1371/journal.pgen.1002770, doi:10.1371/journal.pgen.1002770. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1002770)